Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1
出版年份 2018 全文链接
标题
Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1
作者
关键词
-
出版物
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume -, Issue -, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-10-28
DOI
10.1007/s40618-018-0963-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MiR-126 reverses drug resistance to TRAIL through inhibiting the expression of c-FLIP in cervical cancer
- (2017) Weijiang Zhang et al. GENE
- Identification of translationally controlled tumor protein in promotion of DNA homologous recombination repair in cancer cells by affinity proteomics
- (2017) Y Li et al. ONCOGENE
- miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer
- (2017) Dong Yang et al. Scientific Reports
- MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells
- (2016) Hao Wang et al. Cancer Cell International
- miR-145 sensitizes gallbladder cancer to cisplatin by regulating multidrug resistance associated protein 1
- (2016) Ming Zhan et al. TUMOR BIOLOGY
- Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas
- (2016) E. Sala et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Expression profiling of O6 methylguanine-DNA-methyl transferase in prolactinomas: a correlative study of promoter methylation and pathological features in 136 cases
- (2015) Xiao-Bing Jiang et al. BMC CANCER
- The role of TGF-β/Smad signaling in dopamine agonist-resistant prolactinomas
- (2015) Zhenye Li et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Tumor suppressor miR-145 reverses drug resistance by directly targeting DNA damage-related gene RAD18 in colorectal cancer
- (2015) Rui-Lei Liu et al. TUMOR BIOLOGY
- MiR-145 Expression Accelerates Esophageal Adenocarcinoma Progression by Enhancing Cell Invasion and Anoikis Resistance
- (2015) Mathieu Francois Derouet et al. PLoS One
- miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6
- (2014) Xiaolan Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma
- (2014) Ruijing Lu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- miR-145 inhibits osteosarcoma cells proliferation and invasion by targeting ROCK1
- (2014) Enqi Li et al. TUMOR BIOLOGY
- miR-145 inhibits invasion of bladder cancer cells by targeting PAK111This study was supported by National Natural Science Foundation of China (No. 81372279 to P. Guo).
- (2014) Bo Kou et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- miR-145 downregulates the expression of cyclin-dependent kinase 6 in human cervical carcinoma cells
- (2014) JING ZHANG et al. Experimental and Therapeutic Medicine
- Response to microtubule-interacting agents in primary epithelial ovarian cancer cells
- (2013) Ilenia Pellicciotta et al. Cancer Cell International
- Tumor protein translationally controlled 1 is a p53 target gene that promotes cell survival
- (2013) Weimin Chen et al. CELL CYCLE
- A Novel Marine Drug, SZ-685C, Induces Apoptosis of MMQ Pituitary Tumor Cells by Downregulating miR-200c
- (2013) C.-H. Chen et al. CURRENT MEDICINAL CHEMISTRY
- Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: Impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretion
- (2012) Thomas Cuny et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
- (2011) Shlomo Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Translationally controlled tumour protein (TCTP) is a novel glucose-regulated protein that is important for survival of pancreatic beta cells
- (2010) F. Diraison et al. DIABETOLOGIA
- Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin
- (2010) Igor P. Pogribny et al. INTERNATIONAL JOURNAL OF CANCER
- BMI and Metabolic Profile in Patients With Prolactinoma Before and After Treatment With Dopamine Agonists
- (2010) Cintia M. dos Santos Silva et al. Obesity
- Acquired resistance to cabergoline: progression from initially responsive micro to macroprolactinoma
- (2010) M. Alberiche Ruano et al. Pituitary
- Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)
- (2009) Alberto Fernandez et al. CLINICAL ENDOCRINOLOGY
- Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin
- (2009) Guo-Qing Chen et al. MEDICAL ONCOLOGY
- Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
- (2009) B Song et al. ONCOGENE
- Genes Differentially Expressed in Prolactinomas Responsive and Resistant to Dopamine Agonists
- (2008) Vanessa Q. Passos et al. NEUROENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now